Irbesartan treatment does not influence plasma levels of...

Irbesartan treatment does not influence plasma levels of the advanced glycation end products N (1-carboxymethyl)lysine and N (1-carboxyethyl)lysine in patients with type 2 diabetes and microalbuminuria. A randomized controlled trial

Engelen, L., Persson, F., Ferreira, I., Rossing, P., Hovind, P., Teerlink, T., Stehouwer, C. D., Parving, H.-H., Schalkwijk, C. G.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
26
Language:
english
Journal:
Nephrology Dialysis Transplantation
DOI:
10.1093/ndt/gfr102
Date:
November, 2011
File:
PDF, 90 KB
english, 2011
Conversion to is in progress
Conversion to is failed